Teste genético pode mudar a rota do tratamento da fibrose pulmonar
A new Mayo Clinic study shows that integrating telomere length evaluation and genetic testing into pulmonary care can significantly change how physicians diagnose and treat pulmonary fibrosis—in some cases even redirecting the course of care.